Literature DB >> 9581324

Incidence of premenstrual syndrome and remedy usage: a national probability sample study.

B B Singh1, B M Berman, R L Simpson, A Annechild.   

Abstract

CONTEXT: Premenstrual syndrome is believed to affect 30% to 80% of women. Studies in various cultures have used a variety of methodologies to determine prevalence, symptom profile, and effectiveness of available treatments. This study was designed to provide information on incidence of PMS and therapies used based on a national probability sample of US women.
METHOD: In 1996 a national probability sample (N = 1052) of women aged 21 to 64 years was surveyed by telephone using random digit dial methods. The survey included demographic information, questions concerning respondent knowledge of premenstrual syndrome, incidence rates of common premenstrual syndrome symptoms, and any remedies that were used to control the symptoms.
RESULTS: Forty-one percent of the women responded "yes" to the question, "Do you suffer from premenstrual syndrome?" An additional 17% indicated that they experienced symptoms prior to their menstrual cycle that are commonly associated with premenstrual syndrome (e.g., pain, bloating, feeling more emotional, weight gain, food cravings), though without associating these symptoms with premenstrual syndrome explicity. The most frequently noted severe symptom was that of "[feeling] more emotional." Of those reporting premenstrual syndrome symptoms, approximately 42% took either prescription or over-the-counter medications to relieve them. Eighty percent of the women taking any type of medication relied on over-the-counter medications. Prescription drug use for premenstrual syndrome symptoms focused on medications to control pain; hormone supplements were the second most frequently prescribed rugs. Fewer than 3% of the respondents used prescription medications. Respondents were asked to indicate whether they had used a complementary medical therapy to control symptoms. Exercise was used most frequently (18%), and acupuncture was the least frequently used. Although only a small percentage of women used complementary therapies, for most of these therapies a near-perfect concordance was found between usage and belief in efficacy.
CONCLUSIONS: Women were aware of symptoms related to premenstrual syndrome more frequently than they recognized a formalized medical syndrome. Less than half of the women reporting symptoms had taken either over-the-counter or prescription drugs. Those who tried complementary therapies generally found them to be effective.

Entities:  

Mesh:

Year:  1998        PMID: 9581324

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  9 in total

Review 1.  The role of hormones and hormonal treatments in premenstrual syndrome.

Authors:  Torbjörn Bäckström; Lotta Andreen; Vita Birzniece; Inger Björn; Inga-Maj Johansson; Maud Nordenstam-Haghjo; Sigrid Nyberg; Inger Sundström-Poromaa; Göran Wahlström; Mingde Wang; Di Zhu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause.

Authors:  Ellen W Freeman
Journal:  Dialogues Clin Neurosci       Date:  2002-06       Impact factor: 5.986

3.  Prevalence, impacts and medical managements of premenstrual syndrome among female students: cross-sectional study in College of Health Sciences, Mekelle University, Mekelle, northern Ethiopia.

Authors:  Fikru Wakjira Tolossa; Mebratu Legesse Bekele
Journal:  BMC Womens Health       Date:  2014-03-29       Impact factor: 2.809

Review 4.  Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review.

Authors:  Su Hee Jang; Dong Il Kim; Min-Sun Choi
Journal:  BMC Complement Altern Med       Date:  2014-01-10       Impact factor: 3.659

5.  Characterization of symptoms and edema distribution in premenstrual syndrome.

Authors:  Pascale Mutti Tacani; Danielle de Oliveira Ribeiro; Barbara Evelyn Barros Guimarães; Aline Fernanda Perez Machado; Rogério Eduardo Tacani
Journal:  Int J Womens Health       Date:  2015-03-11

6.  Effect of premenstrual stress on autonomic function.

Authors:  M V Rode; P Kamble; M S Phatak; P Jadhao; P Tayde
Journal:  Ann Neurosci       Date:  2010-07

7.  The use of complementary and alternative medicine by 7427 Australian women with cyclic perimenstrual pain and discomfort: a cross-sectional study.

Authors:  Carole Fisher; Jon Adams; Louise Hickman; David Sibbritt
Journal:  BMC Complement Altern Med       Date:  2016-05-18       Impact factor: 3.659

8.  Beta-Arrestin1 Levels in Mononuclear Leukocytes Support Depression Scores for Women with Premenstrual Dysphoric Disorder.

Authors:  Farzana Alam; Sanket Nayyar; William Richie; Anthony Archibong; Tultul Nayyar
Journal:  Int J Environ Res Public Health       Date:  2015-12-22       Impact factor: 3.390

9.  Premenstrual Syndrome: Symptomatic and Diagnosed Prevalence, Dualistic Treatment Approach - A Cross-Sectional Study in Ukraine.

Authors:  Edith Meszaros Crow; Emilien Jeannot
Journal:  Int J Prev Med       Date:  2017-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.